Cargando…
Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: To assess the efficacy of local intranasal treatment with budesonide (nasal irrigation), in addition to olfactory rehabilitation, in the management of loss of smell in COVID-19 patients without signs of severity and with persistent hyposmia 30 days after the onset of symptoms. To search...
Autores principales: | Daval, Mary, Corré, Alain, Palpacuer, Clement, Housset, Juliette, Poillon, Guillaume, Eliezer, Michael, Verillaud, Benjamin, Slama, Dorsaf, Ayache, Denis, Herman, Philippe, Jourdaine, Clement, Hervé, Camille, El Bakkouri, Wissame, Salmon, Dominique, Hautefort, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370627/ https://www.ncbi.nlm.nih.gov/pubmed/32690074 http://dx.doi.org/10.1186/s13063-020-04585-8 |
Ejemplares similares
-
Tophaceous gout of the middle ear
por: Gargula, Stéphane, et al.
Publicado: (2019) -
Infliximab for the Treatment of Inflammatory Labyrinthitis: A Retrospective Cohort Study
por: Djian, Cassandre, et al.
Publicado: (2023) -
The Effect of Topical Aminophylline on Hyposmia and Anosmia
por: Jahandideh, Hesam, et al.
Publicado: (2022) -
Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study
por: Salmon Ceron, Dominique, et al.
Publicado: (2020) -
Multimodal strategy for the management of sphenoid osteoradionecrosis: Preliminary results
por: Daoudi, Hannah, et al.
Publicado: (2020)